secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zenas BioPharma, Inc. (ZBIO)
CIK:        0001953926
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001104659-25-058892
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zenas BioPharma holds 2025 annual meeting; director Ting Xiao not re-elected, board reduced to 8
--------------------------------------------------------------------------------

- Leon O. Moulder, Jr. and Hongbo Lu, Ph.D. elected as Class I directors for three-year terms.
- Vote totals: Moulder 34,077,048 for; Lu 33,266,315 for; broker non-votes 1,467,979 each.
- Board size reduced from 9 to 8 upon departure of Ting Xiao, who did not stand for re-election.
- Ratification of Ernst & Young LLP as independent auditor for fiscal 2025 approved with 35,856,550 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1953926/000110465925058892/0001104659-25-058892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1953926/000110465925058892/tm2517793d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer